Regulation - LGIC

College of Dental Hygienists of Ontario

Regulation Number(s):
381/17
Instrument Type:
Regulation - LGIC
Bill or Act:
Act
Summary of Decision:
The Ontario Regulation 381/17 was filed with the Registrar of Regulations as O. Reg. 381/17 (Designated Drugs) under the Dental Hygiene Act, 1991 on September 29, 2017. The regulation was published on e-laws on September 29, 2017 and was published in the Ontario Gazette on October 14, 2017.
Further Information:
Proposal Number:
14-HLTC016
Posting Date:
October 27, 2014
Summary of Proposal:
Posted as an Information Item.

College Introduction

In Ontario, the regulation of health professions is based on a self-governance model. There are 23 health regulatory colleges governing 25 health professions under the Regulated Health Professions Act, 1991 (RHPA) and their respective health profession Acts. Health regulatory colleges operate at arm's length from the provincial government and independently administer their own internal processes.

Under the RHPA and the Dental Hygienist Act, 1991, the College of Dental Hygienists of Ontario ("College") is responsible for governing the profession of dental hygienists in Ontario. Under these Acts, the College has the authority to make regulations on a variety of subject matters, including prescribing, dispensing, compounding and selling of drugs. All College regulations are subject to the prior review by the Minister of Health and Long-Term Care and the approval of the Lieutenant Governor in Council.

Summary of Proposal

In 2009, the Ontario government passed Bill 179, the Regulated Health Professions Statute Law Amendment Act, 2009. The legislation expanded access to controlled acts for several regulated health professions, including dental hygiene.

The proposed regulation was originally circulated to members and stakeholders for feedback February 2013. The proposed regulation would permit dental hygienists to prescribe, dispense, compound, and sell drugs. The regulation limits the prescribing, dispensing, compounding or selling of a drug to anticariogenics (fluoride and its salts) and antimicrobials (chlorhexidine and its salts).

The proposal also allows for dental hygienists to use in their practice:
• an anti-microbial drug or anticariogenic drug administered orally or topically including sub-gingival or sub-lingual delivery systems,
• an anaesthetic drug administered topically including sub-gingival or sub-lingual delivery systems, and
• a drug that may, without a prescription, be lawfully purchased or acquired if it is administered orally or topically including sub-gingival or sub-lingual delivery systems.

Alternatively, the College may be contacted at the following address.
Contact Address:
Contact: Feedback
Phone: 416-961-6234
Email: ndalcourt@cdho.org
Address: 69 Bloor St. East, Suite 300 Toronto, ON M4W 1A9
Website: www.cdho.org
Effective Date:
September 29, 2017
Decision:
Approved